Summit Therapeutics has filed a notice of an exempt offering of securities to raise $199,999,998.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Summit Therapeutics is raising up to $199,999,998.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Manmeet Soni played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Summit Therapeutics
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate. We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol SMMT). We are headquartered in Miami, Florida, and we have additional offices in Menlo Park, California, and Oxford, UK.
To learn more about Summit Therapeutics, visit http://www.smmttx.com/
Company Linkedin Page: https://www.linkedin.com/company/summit-therapeutics/
Contact:
Manmeet Soni, Chief Financial Officer
305-203-2034
https://www.linkedin.com/in/manmeetsoni/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.